In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Zai Lab Limited ADR (NASDAQ: ZLAB) closed at $28.96 down -6.85% from its previous closing price of $31.09. In other words, the price has decreased by -$6.85 from its previous closing price. On the day, 1.08 million shares were traded. ZLAB stock price reached its highest trading level at $31.06 during the session, while it also had its lowest trading level at $27.74.
Ratios:
For a deeper understanding of Zai Lab Limited ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.29 and its Current Ratio is at 3.46. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 14, 2023, initiated with a Overweight rating and assigned the stock a target price of $47.50.
On August 10, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $70.
On January 21, 2022, Macquarie started tracking the stock assigning a Outperform rating and target price of $64.Macquarie initiated its Outperform rating on January 21, 2022, with a $64 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 04 ’24 when Chen Yajing sold 167 shares for $30.66 per share. The transaction valued at 5,121 led to the insider holds 15,494 shares of the business.
Chen Yajing bought 167 shares of ZLAB for $5,121 on Nov 04 ’24. On Oct 02 ’24, another insider, Chen Yajing, who serves as the Chief Financial Officer of the company, sold 301 shares for $25.40 each. As a result, the insider received 7,645 and left with 15,161 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZLAB now has a Market Capitalization of 2953282816 and an Enterprise Value of 27874924544. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.90 while its Price-to-Book (P/B) ratio in mrq is 4.04. Its current Enterprise Value per Revenue stands at 86.377 whereas that against EBITDA is -81.128.
Stock Price History:
Over the past 52 weeks, ZLAB has reached a high of $36.60, while it has fallen to a 52-week low of $13.48. The 50-Day Moving Average of the stock is 13.24%, while the 200-Day Moving Average is calculated to be 44.32%.
Shares Statistics:
For the past three months, ZLAB has traded an average of 747.93K shares per day and 800190 over the past ten days. A total of 99.12M shares are outstanding, with a floating share count of 98.53M. Insiders hold about 0.59% of the company’s shares, while institutions hold 42.09% stake in the company. Shares short for ZLAB as of 1728950400 were 4749012 with a Short Ratio of 6.23, compared to 1726185600 on 5415759. Therefore, it implies a Short% of Shares Outstanding of 4749012 and a Short% of Float of 5.4899998.
